A Trial of Nadolol Plus Isosorbide Mononitrate Versus Carvedilol for the Prevention of Variceal Rebleeding
Condition(s):Variceal RebleedingLast Updated:October 26, 2010Completed
Hide Studies Not Open or Pending
Condition(s):Variceal RebleedingLast Updated:October 26, 2010Completed
Condition(s):Chronic Hemodialysis (ESRD)Last Updated:April 27, 2021Completed
Condition(s):Coronary Artery Stenosis; Coronary Heart DiseaseLast Updated:August 5, 2014Completed
Condition(s):Cerebral Small Vessel Diseases; Cognitive Impairment; StrokeLast Updated:January 19, 2018Completed
Condition(s):Pulmonary Edema; Congestive Heart Failure; Acute Heart FailureLast Updated:October 25, 2023Recruiting
Condition(s):Heart Failure; Congestive Heart FailureLast Updated:June 21, 2022Completed
Condition(s):Stable AnginaLast Updated:June 2, 2014Unknown status
Condition(s):Duchenne Muscular Dystrophy (DMD)Last Updated:August 31, 2018Completed
Condition(s):Unstable Angina; Myocardial InfarctionLast Updated:January 28, 2010Withdrawn
Condition(s):Gastrointestinal Hemorrhage; Portal Hypertension; CirrhosisLast Updated:March 21, 2007Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.